[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:myeloid-neoplasm":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":72,"states":73},"Myeloid Neoplasm",10,9,[8,16,23,29,35,41,47,53,59,65],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06594445","HM2023-05: GTB-3650 Trike for High Risk MDS and R\u002FR AML",[12],"Phase 1","RECRUITING","2026-08-26T02:15:18.897219Z","2026-05-05T02:43:29.190364Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT04797767","Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:15.214990Z","2026-04-29T02:57:57.089926Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07112287","Germline Testing for Predisposition to Myeloid Malignancies",[],"2026-08-26T02:15:57.572488Z","2026-05-05T02:43:29.141627Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06295965","Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study",[],"2026-08-26T02:19:06.150683Z","2026-05-13T02:55:06.433546Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT04981821","A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms",[],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:29.473763Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07094750","Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms",[],"2026-08-26T02:17:03.534765Z","2026-07-19T19:36:05.065181Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT06710418","Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma\u002FLeukemia",[],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:27.808498Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":57,"content_modified":58},"NCT07263074","Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories",[],"2026-08-26T02:17:22.153941Z","2026-07-19T19:36:05.066279Z",{"nct_id":60,"title":61,"phases":62,"status":13,"updated_at":63,"content_modified":64},"NCT05875805","A Telehealth Advance Care Planning Intervention",[],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:29.354626Z",{"nct_id":66,"title":67,"phases":68,"status":69,"updated_at":70,"content_modified":71},"NCT06090513","Molecular Services and EMR-Lab Integration Application (ELIA) for Reducing Healthcare Disparities in Cancer Patients",[],"NOT_YET_RECRUITING","2026-08-26T02:18:57.189473Z","2026-05-13T02:55:06.414689Z",[],[74,78],{"state":75,"count":76,"slug":77},"Washington",4,"washington",{"state":79,"count":80,"slug":81},"New York",3,"new-york"]